TAVEXIA LIFECARE LIMITED

TAVEXIA LIFECARE LIMITED

BBSE:TAVEXIA
1.17
INR
0.00
(0.00%)
-0.02EPS
287.70MMarket Cap
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
0.23
0.21
0.16
0.23
0.01
0.07
0.21
0.25
0.14
0.16
0.23
0.84
0.82
Basic EPS, GAAP
- -
- -
- -
0.01
-0.01
- -
0.07
- -
0.04
0.05
0.11
0.01
-0.01
Free Cash Flow per Basic Share
-0.15
-0.16
0.15
-0.23
- -
-0.01
-0.11
-0.19
-0.18
-0.12
- -
-0.37
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.53
0.53
0.53
0.53
0.52
0.52
0.6
0.61
1.02
0.97
1.05
1.13
- -
Tangible Book Value per Share
0.53
0.53
0.53
0.53
0.52
0.52
0.6
0.61
1.02
0.97
1.05
1.13
- -
Basic Weighted Avg Shares
59
49
48
61
61
61
61
61
153
229
229
384
388
Sales/Revenue/Turnover
14
10
8
14
1
4
13
15
22
36
53
322
317
Operating Margin (%)
-2.84
-9.11
-13.58
4.71
-155.05
8.46
49.86
2.6
35.76
43.49
53.83
-17.32
-21.33
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
1
2
4
4
6
6
Net Income, GAAP
- -
- -
- -
- -
-1
- -
4
- -
6
12
25
2
-4
Effective Tax Rate (%)
90.48
30.9
29.87
25.75
- -
25
26.01
50
27.35
22.31
21.88
- -
- -
Profit Margin (%)
0.12
0.26
0.66
3.16
-129.03
0.38
34.16
1.3
25.01
33.5
47.3
0.66
-1.18
Working Capital
32
25
25
33
32
32
35
35
59
102
122
266
- -
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
4
4
- -
Total Equity
32
32
32
33
32
32
36
37
155
222
240
435
- -
Return on Invested Capital (%)
- -
-0.45
-2.27
1.07
- -
0.82
13.2
0.51
5.79
6.2
9.32
- -
- -
Return on Capital (%)
- -
0.89
0.16
1.38
- -
1.37
13.61
0.79
5.91
6.31
10.79
- -
- -
Return on Common Equity (%)
- -
0.08
0.16
1.38
-2
0.05
12.9
0.54
5.77
6.32
10.79
0.63
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
31
- -
LT Borrowings
- -
4
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
384
384
384
Market Capitalization
272
280
288

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
940
- -
Cash, Cash Equivalents & STI
- -
14
- -
Accounts Receivable, Net
- -
110
- -
Inventories
- -
77
- -
Total Current Liabilities
- -
674
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
31
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
46.57%
90.46%
81.71%
Free Cash Flow
-1,241.42%
-2,629.07%
-13,256.15%
Net Income, GAAP
3,011.08%
540.95%
-91.5%
Sales/Revenue/Turnover
160.4%
136.88%
512.74%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
7
16
20
11
53
2026
12
168
57
85
322
2027
6
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
0.01
0.03
0.03
0.04
0.11
2026
0.03
0.02
-0.01
-0.01
0.01
2027
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

CEO
Mit Tarun Bharmbhatt
Sector
Producer manufacturing
Industry
Building products
Address
Mumbai India
IPO Date
Dec 24, 2015
Business
Tavexia Lifecare Limited is an India-based company engaged in the manufacturing, trading, marketing, and distribution of lifestyle wellness products, home fragrance appliances, personal healthcare equipment, and decorative lighting solutions. The company offers a diverse portfolio of consumer wellness and ambient lifestyle products, which includes electric, wooden, and ceramic Kapoor Dani (camphor burners); traditional Bakhoor Dani incense burners; ultrasonic and timer-equipped aroma diffusers; pure essential oils, camphor tablets, and fragrance refills; personal healthcare appliances, such as facial steamers, vaporizers, and steam inhalers; and decorative ambient lighting solutions, including LED aroma lamps, multi-functional table lamps, and customized wooden burners with artistic motifs marketed under brand names such as Brilliance with Time and Time Therapy. The company caters to individual consumers, residential spaces, and commercial establishments across India through a multi-channel sales and distribution infrastructure comprising major online e-commerce platforms, third-party marketplaces, regional distributors, and retail networks. Originally incorporated on August 14, 1980, the company is headquartered in Mumbai, Maharashtra, India, and its equity shares are listed on the BSE. In recent periods, the company has undertaken a significant strategic reorganization, transitioning from its legacy commercial trading and financial dealing operations to concentrate exclusively on the lifestyle, wellness, and lifecare sectors. In connection with this strategic refocusing, the company changed its name from Mayukh Dealtrade Limited to Sattva Sukun Lifecare Limited in August 2024, and subsequently rebranded to Tavexia Lifecare Limited in August 2026 following requisite regulatory approvals from the Ministry of Corporate Affairs and stock exchange authorities. Recent operational advancements encompass the rollout of automated and smart-timer diffuser collections, the expansion of direct-to-consumer digital channels, promoter equity reallocations, and strategic evaluations of expansion opportunities and acquisitions within the broader pharmaceutical and consumer healthcare markets.